Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Johnson & Johnson: A Core Holding for the Long Haul

 

I have just written a report on JNJ in which I reiterated my Buy recommendation. I donít see a vibrant…
Read more…

FDA Cardiovascular and Renal Advisory Committee Goes Against FDA View and Recommends Approval of Xarelto

The FDA had apparently slammed the door shut on approval of Johnson & Johnsonís Xarelto (rivaroxaban) for stroke prevention in…
Read more…